Gilead Sciences Will Outperform and 3 More Analyst Notes to Know About

Stock upgrades and downgrades are a controversial part of Wall Street. Despite regulations, many banks and firms still have a positive bias toward current clients and companies desired as future clients. In addition, Wall Street analysts are straight-up biased to the buy side. The percentage of sell recommendations is normally below 15 percent!

Regardless, upgrades and downgrades move stocks in the short-term. They fall into our CHEAT SHEET framework category ‘C = Catalyst for a Stock?s Movement’. Here are catalysts you must know today:

Gilead Sciences (NASDAQ:GILD): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $50 to $55.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

GILD

Salem Comms (NASDAQ:SALM): B. Riley & Co. reiterated its rating of Buy for this company and changed its price target from $9.5 to $11.25.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

SALM

Uni-Pixel (NASDAQ:UNXL): Ladenburg Thalmann reiterated its rating of Buy for this company and changed its price target from $30 to $40.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

UNXL

Biogen Idec (NASDAQ:BIIB): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $180 to $215.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BIIB

Investing Insights: Will Costco Continue to Explode?